Avon Lifesciences informs about conversion of warrants into equity

28 Nov 2015 Evaluate

Avon Lifesciences has informed that as per the terms of 10,500,000 Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment Committee of the Board of Directors of the Company at the meeting held on November 27, 2015, has upon receipt of balance of 75% consideration aggregating to Rs.1,950,000 has approved allotment of 100,000 Equity Shares upon conversion of equivalent number of warrants at an issue price of Rs. 26 per share.

The above information is a part of company’s filings submitted to BSE.

Kobo Biotech Share Price

4.01 -0.19 (-4.52%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.